Click here to go to the previous page
Management of Apparent Secondary Hypogonadism due to Obesity, Opiates & Anabolic Steroids
Program Code:
CMF02
Date:
Saturday, June 4, 2011
Time:
2:45 PM to 3:05 PM
EST
SPEAKER
(S):
Frederick C Wu, MD,FRCP, Manchester Royal Infirmary
Disclosures: FCW: Consultant, Bayer Schering Pharma, Eli Lilly & Company.
Richard Arthur Bebb, MD,FRCP, Univ of British Columbia
Disclosure: Nothing to Disclose